
Please try another search
Investing.com -- Novartis (SIX:NOVN) on Thursday posted a 24% rise in second-quarter net income to $4 billion, as sales of key therapies including Kisqali and Entresto drove performance in the...
Investing.com - Shares of European drugmakers slipped on Wednesday after U.S. President Donald Trump said that tariffs of up to 200% on pharmaceutical imports could be coming "very soon." In...
Investing.com -- Novartis (SIX:NOVN) received approval in Switzerland for Coartem Baby, the first drug specifically designed to treat malaria in babies and young children. The pharmaceutical...
Investing.com -- Novartis (SIX:NOVN) on Monday said that its cancer drug Pluvicto showed positive results in a late-stage trial for patients with an earlier form of advanced prostate cancer. The...
Investing.com - U.S. President Donald Trump on Monday signed an executive order aimed at boosting domestic pharmaceutical production, and warned that he will soon impose import tariffs on the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review